Skip to main content

CORRECTION article

Front. Pharmacol., 01 August 2024
Sec. Drug Metabolism and Transport
Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1451951

Corrigendum: Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury

This article is a correction to:

  1. Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury

    1. Read original article
Xinzhu Zhang,&#x;Xinzhu Zhang1,2†Wu Xiong,&#x;Wu Xiong1,3†Guang Kong,,&#x;Guang Kong1,4,5†Yushan Zhen&#x;Yushan Zhen6†Qiang Zeng&#x;Qiang Zeng1†Siming Wang,Siming Wang1,3Sheng Chen Sheng Chen5*Jun Gu Jun Gu7*Cong Li, Cong Li1,3*Kaijin Guo, Kaijin Guo1,2*
  • 1Nanjing Medical University, Nanjing, China
  • 2Department of Orthopedics, The First Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
  • 3Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • 4Gusu School, Nanjing Medical University, Suzhou, China
  • 5Department of Orthopedics, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou, China
  • 6Medical College of Jiangsu University, Zhenjiang, China
  • 7Department of Orthopedics, Xishan People’s Hospital, Wuxi, China

A Corrigendum on
Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury

by Zhang X, Xiong W, Kong G, Zhen Y, Zeng Q, Wang S, Chen S, Gu J, Li C and Guo K (2022). Front. Pharmacol. 13:957433. doi: 10.3389/fphar.2022.957433

In the published article, there was an error regarding the Affiliations for Kaijin Guo. As well as having affiliation 2, they should also have 1 Nanjing Medical University, Nanjing, China.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: spinal cord injury, spermine-functionalized acetalated dextran, paclitaxel, chondroitin sulfate proteoglycan inhibition, spinal cord injury

Citation: Zhang X, Xiong W, Kong G, Zhen Y, Zeng Q, Wang S, Chen S, Gu J, Li C and Guo K (2024) Corrigendum: Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury. Front. Pharmacol. 15:1451951. doi: 10.3389/fphar.2024.1451951

Received: 20 June 2024; Accepted: 24 July 2024;
Published: 01 August 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Zhang, Xiong, Kong, Zhen, Zeng, Wang, Chen, Gu, Li and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sheng Chen, 39889289@qq.com; Jun Gu, 13961753399@163.com; Cong Li, licong@njmu.edu.cn; Kaijin Guo, 15052001509@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.